The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago ...

The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of ...

An unusual placebo effect in Aligos Therapeutics’ Phase IIa trial is driving shareholder skepticism for its metabolic ...

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...

Job security is a hot topic among biopharma professionals. A career coach offers advice for how to evaluate and build it up ...

LOS ANGELES, Sept. 18, 2024 /PRNewswire/ -- Ahara Corporation, announced today its adding doctor-prescribed compounded GLP-1/GIP weight loss medications to its personalized nutrition offering. The ...

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for the ...

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel, Sept.